Skip to main content Skip to section navigation Skip to footer
Partnering Careers
IMV Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • DPX Delivery Platform
    • Overview
    • Scientific Materials
  • Pipeline
    • Overview
    • Maveropepimut-S
    • Expanded Access
  • News & Media
    • Press Releases
    • Events
    • Email Alerts
  • Investors
    • Overview
    • Press Releases
    • Events, Webcasts & Presentations
    • Financial Info
    • Stock Data
    • Filings
    • Governance
    • Contacts
    • FAQ
  • Contact
    • Get in Touch
    • Safety & Respect
  • Partnering
  • Careers

Press Releases

Investors

Investors

  • Overview
  • Press Releases
  • Events, Webcasts & Presentations
    • Overview
    • IR Calendar
    • Presentations
    • Scientific Materials
    • Email Alerts
  • Financial Info
    • Financial Results
    • Tax Information
    • Proxy Information
    • Stock Option Plan
    • Deferred Share Unit Plan
  • Stock Data
    • NASDAQ: IMV
    • TSX: IMV
    • Analyst Coverage
  • Filings
    • SEC Filings
    • SEDAR
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contacts
  • FAQ
Jul 08, 2022 4:05pm EDT

IMV Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Jun 30, 2022 7:05am EDT

IMV Announces Annual and Special Meeting of Shareholders Voting Results

Jun 22, 2022 7:05am EDT

IMV Strengthens Its Financial Position With the $US10 Million Drawdown From Its Existing Long-Term Debt Facility

May 17, 2022 8:05am EDT

IMV Inc. to Present at the H.C. Wainwright Global Investment Conference

May 13, 2022 7:05am EDT

IMV Inc. Announces First Quarter 2022 Financial and Operational Results

May 06, 2022 7:05am EDT

IMV Inc. to Announce First Quarter 2022 Results and Host a Conference Call and Webcast on May 13, 2022

Apr 28, 2022 7:05am EDT

IMV’s Lead Compound to Be Showcased in Two Presentations at the 2022 ASCO Annual Meeting

Apr 22, 2022 7:05am EDT

IMV Inc. Names Michael P. Bailey Chairman of The Board

Apr 08, 2022 5:00pm EDT

IMV Inc. Presents Clinical Benefit of MVP-S in Combination with Pembrolizumab in Bladder Cancer at the AACR Annual Meeting

Apr 06, 2022 7:05am EDT

IMV to Present at IMMUNOLOGY™ 2022, the AAI Annual Meeting

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • …Page 43
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
  • Visit us on Twitter

    Twitter

  • Visit us on LinkedIn

    LinkedIn

  • Visit us on Youtube

    Youtube

© IMV Inc. All Rights Reserved.
Privacy Policy Terms of Use Sitemap Manage Cookie Preferences